In this interview, we delve into the remarkable story of how Dr. Upendra Quenim, the Group Chief Quality Officer of Klybeck Life Sciences SA, embarked on his path to excellence in the pharmaceutical industry. Join us as Dr. Quenim shares insights into his leadership philosophy, achievements, adaptability in an ever-changing business landscape, and the values that continue to shape his vision. Discover what makes Klybeck Life Sciences stand out in the global pharmaceutical arena and how Dr. Quenim continues to influence the sector through resilience, innovation, and strategic foresight. This is the story of an exceptional leader whose decades-long dedication continues to inspire professionals across the globe.
Leadership Qualities That Defined the Journey
Dr. Upendra Quenim attributes his leadership success to a clear sense of direction, a foundation of honest hard work, and the ability to communicate technical perspectives effectively. His focus has always been on target achievement, making sound decisions even under pressure, and ensuring accountability in team outcomes. With an open mind toward change and a resilient approach to uncertainty, Dr. Quenim has successfully aligned team collaboration with overarching organizational goals. His seamless integration with highly supportive teams and top-level directives from leadership played a pivotal role in this alignment. Communication excellence, ongoing technical updates, and an adaptive mindset to evolving business environments have further reinforced his leadership journey.
Key Industry Trends and Challenges for 2025 and Beyond
According to Dr. Upendra Quenim, the pharmaceutical and life sciences industry faces critical challenges in 2025 and beyond, including global market shifts, technology disruptions, evolving consumer behavior, and regulatory complexities. Rising concerns such as antimicrobial resistance in animals, stringent regulations across agencies like the US FDA, EMA, APVMA, and SFDA, and escalating R&D costs particularly in vaccines, probiotics, and immunomodulators are noteworthy. While the growing traction of vaccines, probiotics, and monoclonal antibodies offers opportunities, it demands heavy investments. Additionally, geopolitical instability continues to disrupt supply chains, making logistics management and workforce training vital. With the growing pet care industry and heightened consumer awareness about ethical practices and animal welfare, competition has intensified due to mergers and acquisitions.
Preparing Klybeck Life Sciences for a Dynamic Future
As Group Chief Quality Officer and technical advisor for Quality, Regulatory Affairs, and Formulation Development at Klybeck Life Sciences SA, Dr. Upendra Quenim plays a key role in future-proofing the organization. He collaborates with a global think tank comprising experts from Morocco, Croatia, Switzerland, India, Turkey, the UK, Brazil, and Peru. With visionary leadership from Mr. Abdul Hameed Al Ansari (President & Owner) and Mr. Abdullah Al Ansari (CEO), Klybeck champions complete sustainable solutions for flora and fauna. The company spans six business verticals—Veterinary Pharma, Vaccines, Agri and Public Health, Feed and Food Products, Specialized Pet Products, and Turnkey Projects. Innovations like QbD (Quality by Design), PAT (Process Analytical Technology), and robust management systems are ingrained into its operations. The organization emphasizes continuous improvement through risk management, employee feedback, automation, and strong post-sales customer service. Under Mr. Abdul Hameed Al Ansari’s strategic guidance, Dr. Quenim and the team balance empathy with performance excellence, shaping a resilient future.
Overcoming Obstacles and Building Resilience
Dr. Upendra Quenim’s 40-year journey in the pharmaceutical sector is a testament to endurance and commitment. With early encouragement from family and mentorship from Mr. P. G. Dalvi, who introduced him to the pharmaceutical field, Dr. Quenim began his career by embracing learning, adapting to rigorous studies and industry demands. Each setback became a learning opportunity, prompting strategic recalibration and a resilient comeback. Influential leaders like Dr. Vinay Nayak, Dr. Rajendra Agarwal, Mr. M. S. Theivendran, and Mr. Abdul Hameed Al Ansari inspired his pursuit of excellence. Academic luminaries such as Prof. H. P. Tipnis, Prof. V. M. Kulkarni, and Prof. P. R. Vavia deeply influenced his intellectual foundation. From these mentors, Dr. Quenim internalized the principle that there is no substitute for hard work and lifelong learning.
Fostering a Culture of Innovation
At Klybeck, Dr. Upendra Quenim fosters innovation through structured experimentation, continuous learning, and cross-functional collaboration. Employees benefit from both on-site and off-site training, regular brainstorming sessions, and a work culture that values idea sharing. Worthy contributions are recognized and rewarded, reinforcing an innovative mindset across teams. Technology adoption, big data, and data analytics play crucial roles in strategic advancement, positioning the organization for ongoing progress.
Influential Resources and Learning Experiences
Dr. Upendra Quenim’s leadership approach has been shaped by extensive training programs, academic literature, and real-world experiences. Programs at leading pharmaceutical firms like Merck and Sun Pharma, along with seminars and international exhibitions such as IPC and CPHI, broadened his perspective. Professional certifications in GMP and ISO standards, and audits conducted by firms like KPMG, Deloitte, and PWC further honed his expertise. First-hand experiences in global vendor audits, regulatory inspections, and research leadership enriched his understanding of the industry. The humility, empathy, and grounded nature of his mentors remain core to his leadership style.
Building High-Performance Teams
Under Dr. Upendra Quenim’s leadership, Klybeck places great emphasis on hiring individuals whose qualifications align with the company’s vision and values. Roles and expectations are clearly defined, ensuring accountability and mission alignment. An open communication culture fosters trust, while diverse perspectives lead to collaborative synergy. Personal and professional development are embedded into the company’s training programs, empowering managers and emerging leaders. The company’s top leadership, including the President and CEO, lead by example—cultivating a workplace culture rooted in ethics, empowerment, and continuous improvement.
Social and Environmental Responsibility in Business
Klybeck Life Sciences, under the guidance of Dr. Upendra Quenim and the Legal and Compliance Cell, integrates social and environmental responsibility into its core operations. The organization adheres to a comprehensive Code of Ethics endorsed by its President and Founder. Sustainable practices include waste reduction, energy conservation, and ethical sourcing. Klybeck ensures its suppliers uphold principles of fair labor and environmental care. The company actively aligns with Saudi Arabia’s Vision 2030, complying with guidelines from the Industry Ministry, SFDA, and MODON to safeguard environmental and public health. Customer feedback is integral to refining practices that resonate with shared values and contribute positively to the global ecosystem.
Digital Transformation as a Strategic Imperative
Recognizing the transformative potential of digital tools, Dr. Upendra Quenim supports Klybeck’s approach to embracing technology based on strategic necessity. A dedicated IT department manages digital literacy, system upgrades, and cloud-based infrastructure. Decision Tree Designs help prioritize digital adoption to streamline operations, enhance efficiency, and improve customer service. Platforms enabling remote work and real-time data analytics bolster strategic decision-making. Investment in cybersecurity protects the company’s digital assets. Klybeck’s digital transformation philosophy is guided by the principle of thoughtful integration, ensuring innovation is purpose-driven rather than trend-driven.
Skills Essential for Business Success
Dr. Upendra Quenim emphasizes that a successful business leader must combine strong communication skills with critical thinking, leadership, time management, and financial literacy. At Klybeck, these qualities are exemplified by the President, CEO, and leadership team, who navigate challenges with emotional intelligence, technological proficiency, and strategic clarity. The company’s workforce is its greatest asset, with a shared vision that drives innovation and resilience.
Why Dr. Upendra Quenim’s Leadership Journey Matters
Dr. Upendra Quenim’s professional journey stands as a model of perseverance, integrity, and continual growth. Over four decades, he has embraced challenges, evolved through setbacks, and remained committed to lifelong learning. With unwavering support from his family—including his wife Prita and daughter Santoshi—and professional guidance from distinguished management teams, Dr. Quenim has thrived through a blend of intellect, willpower, and adaptability. His message to aspiring professionals emphasizes the absence of shortcuts in success and the irreplaceable value of sincere effort and education. He also believes that family should be integrated into the success journey to maintain harmony between personal and professional spheres.
Future Influence on the Business Landscape
In his current role, Dr. Upendra Quenim focuses on mentoring, technical advisory, and data-driven decision-making. He continues to influence product development, cost-effective R&D, and global regulatory projects. His strategic involvement at the C-level supports Klybeck’s long-term vision, led by the President and Board of Directors. His expertise remains pivotal in shaping the company’s innovation, compliance, and global growth agenda.
Milestones and Career Achievements
Dr. Upendra Quenim, an Indian national holding a Ph.D. in Pharmaceutical Technology and a Master’s in Pharmaceutical Analysis, currently serves as the Group Chief Quality Officer of Klybeck Life Sciences SA, a USD 100 million enterprise with a global presence. Over the years, he has received numerous accolades including the National Merit Scholarship, Best Ph.D. Thesis Award from UDCT, and several industry honors. His specialization spans GMP, ISO audits, analytical research, technology transfers, and regulatory affairs. Dr. Quenim has successfully led projects for industry giants like Cipla and Johnson & Johnson, contributed to academia as a Ph.D. examiner, and conducted global audits and quality training programs. His leadership was celebrated in Passion Vista’s “Men Leaders to Look Upto” (2023), and he has received prestigious honors including the White Page Global 200 Inspirational Leaders Award, Health 2.0 Outstanding Leadership Award, and Pharma Ratna Universe Award. Additionally, he has played a vital role in social causes such as child care, education, elder support, and pandemic relief efforts, further cementing his legacy as a compassionate and visionary leader.
In conclusion, Dr. Upendra Quenim’s journey is one of deep-rooted commitment, integrity, and transformative leadership in the pharmaceutical and life sciences sector. His career reflects a rare blend of technical expertise, strategic foresight, and human values—making him a beacon for aspiring professionals and industry veterans alike. With unwavering dedication to quality, innovation, and ethical responsibility, Dr. Quenim continues to contribute meaningfully to global healthcare and sustainable business practices. His legacy stands not just in achievements, but in the inspiration he offers to those determined to lead with purpose and vision.
